8 commercial payer policies list J7314. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
8 policies from 8 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of J7314 |
|---|---|---|
| Fluocinolone Acetonide Intra-vitreal Implant (Retisert, Yutiq and Iluvien) | Jan 5, 2024 | Covered |
| Policy | Effective | Status of J7314 |
|---|---|---|
| Intravitreal, Punctum, and Intracameral Implants | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J7314 |
|---|---|---|
| Intravitreal, Punctum, and Intracameral Implants | Jan 1, 2026 | Covered |
| Policy |
|---|
| Effective |
|---|
| Status of J7314 |
|---|
| Intravitreal, Punctum, and Intracameral Implants | Jan 1, 2026 | Covered |
|---|
| Policy | Effective | Status of J7314 |
|---|---|---|
| Intravitreal, Punctum, and Intracameral Implants | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J7314 |
|---|---|---|
| Intracanalicular and Intravitreal Corticosteroid Implants | Aug 1, 2026 | Covered |
| Policy | Effective | Status of J7314 |
|---|---|---|
| Intracanalicular and Intravitreal Corticosteroid Implants | Aug 1, 2026 | Covered |
| Policy | Effective | Status of J7314 |
|---|---|---|
| Intracanalicular and Intravitreal Corticosteroid Implants | Aug 1, 2026 | Covered |